DPT treatment in U87 xenografts suppressed tumor growth via NAD+ depletion and parthanatos induction, identifying TAX1BP1 as a key mediator of parthanatos in gliomas (Wang et al., 2023[150]). Here, TAX1BP1 is linked to glioma.